End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 27 | Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab | CI |
Feb. 15 | Kintara Therapeutics Continues to Evaluate Strategic Options | CI |
- Stock
- Equities
- Stock Kintara Therapeutics, Inc.
- Stock DelMar Pharmaceuticals Inc - OTC Bulletin Board
- News DelMar Pharmaceuticals Inc